日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Implementation of a High-Throughput Pilot Screen in Peptide Hydrogel-Based Three-Dimensional Cell Cultures

在基于肽水凝胶的三维细胞培养中实施高通量中试筛选

Worthington, Peter; Drake, Katherine M; Li, Zhiqin; Napper, Andrew D; Pochan, Darrin J; Langhans, Sigrid A

Interview with Haian Fu, PhD

对傅海安博士的采访

Fu, Haian; Napper, Andrew D

Targeted drug discovery for pediatric leukemia

针对儿童白血病的靶向药物研发

Napper, Andrew D; Watson, Venita G

Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screening.

通过肌营养不良蛋白启动子激活筛选发现杜氏肌营养不良症的药物

Moorwood Catherine, Lozynska Olga, Suri Neha, Napper Andrew D, Diamond Scott L, Khurana Tejvir S

Miniaturized High-Throughput Fluorescent Assay for Conversion of NAD(P)H to NAD(P)

用于将 NAD(P)H 转化为 NAD(P) 的微型化高通量荧光检测

Napper, Andrew D; Sivendran, Sharmila

Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype

组织蛋白酶L抑制剂的设计、合成和评价:利用独特的硫代氨基甲酸酯化学类型

Myers, Michael C; Shah, Parag P; Beavers, Mary Pat; Napper, Andrew D; Diamond, Scott L; Smith, Amos B 3rd; Huryn, Donna M

Evaluation of an orthogonal pooling strategy for rapid high-throughput screening of proteases

评估一种用于快速高通量筛选蛋白酶的正交混合策略

Motlekar, Nuzhat; Diamond, Scott L; Napper, Andrew D

Identification and characterization of 3-substituted pyrazolyl esters as alternate substrates for cathepsin B: the confounding effects of DTT and cysteine in biological assays

鉴定和表征 3-取代吡唑酯作为组织蛋白酶 B 的替代底物:DTT 和半胱氨酸在生物学测定中的干扰作用

Myers, Michael C; Napper, Andrew D; Motlekar, Nuzhat; Shah, Parag P; Chiu, Chun-Hao; Beavers, Mary Pat; Diamond, Scott L; Huryn, Donna M; Smith, Amos B 3rd